Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-05T05:05:28.507Z Has data issue: false hasContentIssue false

Chapter 5 - Brain

from Part II - Oncologic applications

Published online by Cambridge University Press:  05 September 2012

Victor H. Gerbaudo
Affiliation:
Brigham and Women's Hospital, Harvard Medical School
Get access

Summary

In the USA, over 44,500 people are diagnosed with primary brain tumors each year, approximately 20,500 of which are malignant (1). Primary brain tumors were the cause of death of approximately 12,920 people in 2009, according to an estimate by the American Cancer Society (2). Over 140,000 people in the USA are diagnosed each year with brain metastases, most commonly from lung, breast, and colon cancer primaries (3, 4). Nuclear imaging plays an important role in the diagnosis and management of both primary and metastatic brain tumors. This chapter will review the brain tumor pathology and clinical management and will discuss the role of nuclear imaging with a particular emphasis on the most common clinical indication for nuclear brain tumor imaging: evaluate for tumor recurrence versus post-radiation necrosis.

Staging

Gliomas

Gliomas are derived from glia which comprise 90% of the cells within the brain and play an important role in cellular homeostasis. Gliomas are subdivided into astrocytic, oligodendroglial, and mixed oligoastrocytic types (Table 5.1).

The WHO classification separates gliomas into Grades I–IV on the basis of histological features. Since they are often heterogeneous, gliomas are classified based on the most malignant sample of tissue analyzed. Low grade gliomas (Grades I–II) are characterized by high cellularity, pleomorphism, and a low cellular proliferation rate or mitotic index. High grade gliomas (Grade III–IV) have high cellularity and pleomorphism and a high mitotic index.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

North American Brain Tumor Coalitionwww.nabraintumor.org/facts.html 2005
American Cancer Societyhttp://www.scribd.com/doc/21686287/Cancer-Facts-and-Figures-Report-2009 2009
Medline Plushttp://www.nlm.gov/medlineplus/print/ency/article/000769.htm 2006
Arnold, SMPatchell, RA.Diagnosis and management of brain metastasesHematol – Oncol Clin N Am 2001 15 1085CrossRefGoogle Scholar
Kleihues, PBurger, PCScheithauer, BW.The new WHO classification of brain tumoursBrain Pathol 1993 3 255CrossRefGoogle ScholarPubMed
Kayama, TTominaga, TYoshimoto, T.Management of pilocytic astrocytomaNeurosurg Rev 1996 19 217CrossRefGoogle Scholar
Lang, FFGilbert, MR.Diffusely infiltrative low-grade gliomas in adultsJ Clin Oncol 2006 24 1236CrossRefGoogle ScholarPubMed
Central Brain Tumor Registry of the United Stateshttp://www.cbtrus.org/reports/2002/2002report.pdf 2002
Smith, JSJenkins, RB.Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implicationsFront Biosci 2000 5 D213CrossRefGoogle ScholarPubMed
Stupp R Mason, WPvan den Bent, MJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med 2005 352 987CrossRefGoogle Scholar
Sawaya, R.Brain metastasis: steel knife or gamma knife?Ann Surg Oncol 2000 7 323CrossRefGoogle ScholarPubMed
Patchell, RATibbs, PAWalsh, JWA randomized trial of surgery in the treatment of single metastases to the brainN Engl J Med 1990 322 494CrossRefGoogle Scholar
Vecht, CJHaaxma-Reiche, HNoordijk, EMTreatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?Ann Neurol 1993 33 583CrossRefGoogle ScholarPubMed
Rock, JPHaines, SRecht, LPractice parameters for the management of single brain metastasisNeurosurg Focus 2000 9CrossRefGoogle ScholarPubMed
Nguyen, TDDeAngelis, LM.Brain metastasesNeurol Clin 2007 25 1173xCrossRefGoogle ScholarPubMed
Hustinx, RPourdehnad, MKaschten, BAlavi, A.PET imaging for differentiating recurrent brain tumor from radiation necrosisRadiol Clin North Am 2005 43 35CrossRefGoogle ScholarPubMed
Langleben, DDSegall, GM.PET in differentiation of recurrent brain tumor from radiation injuryJ Nucl Med 2000 41 1861Google ScholarPubMed
Law, MYang, SWang, HGlioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imagingAm J Neuroradiol 2003 24 1989Google ScholarPubMed
Wong, TZTurkington, TGHawk, TCColeman, RE.PET and brain tumor image fusionCancer J 2004 10 234CrossRefGoogle ScholarPubMed
Chao, STSuh, JHRaja, SLee, SYBarnett, G.The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgeryInt J Cancer 2001 96 191CrossRefGoogle ScholarPubMed
Grossman, RIYousem, DMNeuroradiology: the RequisitesSt. LouisMosby, 1994. xiv
Thrall, JHZiessman, HA.Nuclear MedicineLouisMosby 2001Google Scholar
Lorberboym, MMandell, LRMosesson, REThe role of thallium-201 uptake and retention in intracranial tumors after radiotherapyJ Nucl Med 1997 38 223Google ScholarPubMed
Tie, JGunawardana, DHRosenthal, MA.Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECTJ Clin Neurosci 2008 15 1327CrossRefGoogle ScholarPubMed
Tomura, NHirano, HKato, KUnexpected accumulation of thallium-201 in cerebral infarctionJ Comput Assist Tomogr 1998 22 126CrossRefGoogle ScholarPubMed
Ortega-Lozano, SJdel Valle-Torres, DMGómez-Río, MLlamas-Elvira, JM.Thallium-201 SPECT in brain gliomas: Quantitative assessment in differential diagnosis between tumor recurrence and radionecrosisClin Nucl Med 2009 34 503CrossRefGoogle ScholarPubMed
Benard, FRomsa, JHustinx, R.Imaging gliomas with positron emission tomography and single-photon emission computed tomographySemin Nucl Med 2003 33 148CrossRefGoogle ScholarPubMed
Martin, WHDelbeke, DPatton, JAFDG-SPECT: correlation with FDG-PETJ Nucl Med 1995 36 988Google ScholarPubMed
Reivich, MKuhl, DWolf, AThe [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in manCirc Res 1979 44 127CrossRefGoogle Scholar
Phelps, MEHuang, SCHoffman, EJTomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of methodAnn Neurol 1979 6 371CrossRefGoogle ScholarPubMed
Di Chiro, GDeLaPaz, RLBrooks, RAGlucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomographyNeurology 1982 32 1323CrossRefGoogle Scholar
Delbeke, DMeyerowitz, CLapidus, RLOptimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PETRadiology 1995 195 47CrossRefGoogle ScholarPubMed
Hanson, MWGlantz, MJHoffman, JMFDG-PET in the selection of brain lesions for biopsyJ Comput Assist Tomogr 1991 15 796CrossRefGoogle ScholarPubMed
Levivier, MGoldman, SPirotte, BDiagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucoseJ Neurosurg 1995 82 445CrossRefGoogle Scholar
Francavilla, TLMiletich, RSDi Chiro, GPositron emission tomography in the detection of malignant degeneration of low-grade gliomasNeurosurgery 1989 24 1CrossRefGoogle ScholarPubMed
Padma, MVSaid, SJacobs, MPrediction of pathology and survival by FDG PET in gliomasJ Neurooncol 2003 64 227CrossRefGoogle ScholarPubMed
Herholz, KHerscovitch, PHeiss, WD.NeuroPET: Positron Emission Tomography in Neuroscience and Clinical NeurologyBerlinSpringer-Verlag, 2004, xv
De Souza, BBrunetti, AFulham, MJPituitary microadenomas: a PET studyRadiology 1990 177 39CrossRefGoogle ScholarPubMed
Sato, KRorke, LB.Vascular bundles and wickerworks in childhood brain tumorsPediatr Neurosci 1989 15 105CrossRefGoogle ScholarPubMed
Murovic, JANagashima, THoshino, TEdwards, MSDavis, RL.Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridineNeurosurgery 1986 19 900CrossRefGoogle ScholarPubMed
Fulham, MJMelisi, JWNishimiya, JDwyer, AJDi Chiro, G.Neuroimaging of juvenile pilocytic astrocytomas: an enigmaRadiology 1993 189 221CrossRefGoogle Scholar
Roelcke, URadü, EWHausmann, OTracer transport and metabolism in a patient with juvenile pilocytic astrocytoma. A PET studyJ Neurooncol 1998 36 279CrossRefGoogle Scholar
Di Chiro, GHatazawa, JKatz, DARizzoli, HVDe Michele, DJ.Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET studyRadiology 1987 164 521CrossRefGoogle ScholarPubMed
Aide, NBenayoun, MKerrou, KImpact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapyBr J Radiol 2007 80 e67CrossRefGoogle Scholar
Spence, AMMuzi, MMankoff, DA18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matterJ Nucl Med 2004 45 1653Google Scholar
Jager, PLVaalburg, WPruim, JRadiolabeled amino acids: basic aspects and clinical applications in oncologyJ Nucl Med 2001 42 432Google Scholar
Sasajima, TMiyagawa, TOku, TProliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell linesEur J Nucl Med Mol Imaging 2004 31 1244CrossRefGoogle ScholarPubMed
Kracht, LWFriese, MHerholz, KMethyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with gliomaEur J Nucl Med Mol Imaging 2003 30 868CrossRefGoogle ScholarPubMed
Schiepers, CChen, WCloughesy, TDahlbom, MHuang, SC.18F-FDOPA kinetics in brain tumorsJ Nucl Med 2007 48 1651CrossRefGoogle Scholar
Heiss, WDWienhard, KWagner, RF-Dopa as an amino acid tracer to detect brain tumorsJ Nucl Med 1996 37 1180Google ScholarPubMed
Herholz, KHölzer, TBauer, B11C-methionine PET for differential diagnosis of low-grade gliomasNeurology 1998 50 1316CrossRefGoogle ScholarPubMed
Ogawa, TShishido, FKanno, ICerebral glioma: evaluation with methionine PETRadiology 1993 186 45CrossRefGoogle ScholarPubMed
Chen, WCloughesy, TKamdar, NImaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDGJ Nucl Med 2005 46 945Google ScholarPubMed
Salskov, ATammisetti, VSGrierson, JVesselle, H.FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3’-deoxy-3’-[18F]fluorothymidineSemin Nucl Med 2007 37 429CrossRefGoogle ScholarPubMed
Pirotte, BGoldman, SBidaut, LMUse of positron emission tomography (PET) in stereotactic conditions for brain biopsyActa Neurochir (Wien) 1995 134 79CrossRefGoogle ScholarPubMed
Pirotte, BGoldman, SMassager, NComparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomasJ Nucl Med 2004 45 1293Google ScholarPubMed
Pauleit, DFloeth, FHamacher, KO-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomasBrain 2005 128 678CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×